Athena Kritharis
Overview
Explore the profile of Athena Kritharis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
274
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ravi D, Kritharis A, Evens A
Cancers (Basel)
. 2024 Nov;
16(21).
PMID: 39518046
: Warburg's metabolic paradox illustrates that malignant cells require both glucose and oxygen to survive, even after converting glucose into lactate. It remains unclear whether sparing glucose from oxidation intersects...
2.
Ravi D, Beheshti A, Burgess K, Kritharis A, Chen Y, Evens A, et al.
Biomedicines
. 2022 Nov;
10(11).
PMID: 36359241
Biological paths of tumor progression are difficult to predict without time-series data. Using median shift and abacus transformation in the analysis of RNA sequencing data sets, natural patient stratifications were...
3.
Carter J, David K, Kritharis A, Evens A
Curr Treat Options Oncol
. 2020 Apr;
21(5):42.
PMID: 32328822
Older adults with Hodgkin lymphoma (HL), commonly defined as age ≥ 60 years, represent approximately 20% of the total HL population. Historically, they have significantly inferior outcomes compared with younger...
4.
McDonald J, Kritharis A, Beheshti A, Pilichowska M, Burgess K, Ricks-Santi L, et al.
Oncotarget
. 2018 Oct;
9(70):33441.
PMID: 30279973
[This corrects the article DOI: 10.18632/oncotarget.25209.].
5.
Al-Samkari H, Kritharis A, Kuter D
Haematologica
. 2018 Oct;
103(10):e492-e495.
PMID: 30270207
No abstract available.
6.
McDonald J, Kritharis A, Beheshti A, Pilichowska M, Burgess K, Ricks-Santi L, et al.
Oncotarget
. 2018 Jun;
9(32):22693-22702.
PMID: 29854308
T-cell lymphoma (TCL) is an uncommon and aggressive form of human cancer. Lymphoma is the most common hematopoietic tumor in canines (companion animals), with TCL representing approximately 30% of diagnoses....
7.
Kritharis A, Al-Samkari H, Kuter D
Haematologica
. 2018 May;
103(9):1433-1443.
PMID: 29794143
Hereditary hemorrhagic telangiectasia (HHT), also known as Osler-Weber-Rendu syndrome, is an autosomal dominant disorder that causes abnormal blood vessel formation. The diagnosis of hereditary hemorrhagic telangiectasia is clinical, based on...
8.
David K, Kritharis A, Evens A
Lancet Haematol
. 2018 Apr;
5(5):e186-e187.
PMID: 29650494
No abstract available.
9.
Pilichowska M, Pittaluga S, Ferry J, Hemminger J, Chang H, Kanakry J, et al.
Blood Adv
. 2018 Jan;
1(26):2600-2609.
PMID: 29296913
Gray zone lymphoma (GZL) is described as sharing features with classical Hodgkin lymphoma (cHL) and diffuse large B-cell lymphoma (DLBCL). However, there remains complexity in establishing diagnosis, delineating prognosis, and...
10.
Pilichowska M, Kritharis A, Evens A
Hematol Oncol Clin North Am
. 2016 Nov;
30(6):1251-1260.
PMID: 27888879
The morphology of gray zone lymphoma (GZL) is variable with tumor cells spanning the spectrum of diffuse large B-cell lymphoma (DLBCL) and classical Hodgkin lymphoma. The immunophenotype is frequently discordant....